OCTREOTIDE ACETATE (PRESERVATIVE FREE) Drug Patent Profile
✉ Email this page to a colleague
When do Octreotide Acetate (preservative Free) patents expire, and what generic alternatives are available?
Octreotide Acetate (preservative Free) is a drug marketed by Fresenius Kabi Usa, Mylan Institutional, Sagent Pharms Inc, and West-ward Pharms Int. and is included in four NDAs.
The generic ingredient in OCTREOTIDE ACETATE (PRESERVATIVE FREE) is octreotide acetate. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Octreotide Acetate (preservative Free)
A generic version of OCTREOTIDE ACETATE (PRESERVATIVE FREE) was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.
Summary for OCTREOTIDE ACETATE (PRESERVATIVE FREE)
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 827 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OCTREOTIDE ACETATE (PRESERVATIVE FREE) at DailyMed |
Pharmacology for OCTREOTIDE ACETATE (PRESERVATIVE FREE)
Drug Class | Somatostatin Analog |
Mechanism of Action | Somatostatin Receptor Agonists |